Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.9K
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgery in stage IIA/IIB seminoma: A "Living systematic review" and meta-analysis of prospective studies.

Indian journal of urology : IJU : journal of the Urological Society of India·2026
Same author

Long-Term Risk of Alcohol Use Disorder in Testicular Cancer Survivors: A National Veterans Affairs Cohort Study.

Clinical genitourinary cancer·2026
Same author

Advocacy Convergence in Medicine: Analyzing Legislative Priorities and Political Action Committee Overlap Among Major Medical Societies.

Urology practice·2026
Same author

BPI26-018: Integrated Specialty Prostate Cancer Care: Outcomes From a Collaborative Clinic Model at UC San Diego Moores Cancer Center.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same author

HSR26-259: Cryoablation for Locally Recurrent Prostate Cancer After Primary Radiotherapy.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Related Experiment Video

Updated: Mar 15, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Testicular germ cell tumor genomics.

Solomon L Woldu1, James F Amatruda, Aditya Bagrodia

  • 1University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.

Current Opinion in Urology
|September 2, 2016
PubMed
Summary

Understanding testicular germ cell tumor (TGCT) biology improves early-stage metastasis prediction and identifies new treatments for cisplatin-resistant disease. Further molecular analysis offers tailored therapies and better patient outcomes.

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K
Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

16.9K

Related Experiment Videos

Last Updated: Mar 15, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K
Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

16.9K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Testicular germ cell tumors (TGCTs) are highly curable but predicting early-stage metastasis and chemotherapy response remains challenging.
  • Cisplatin-resistant TGCTs have limited treatment options, highlighting the need for novel therapeutic strategies.
  • Understanding TGCT biology is crucial for improved patient counseling and developing targeted therapies.

Purpose of the Study:

  • To review recent molecular findings in TGCT.
  • To identify potential therapeutic targets in cisplatin-resistant TGCT.
  • To explore how advanced molecular characterization can refine treatment strategies.

Main Methods:

  • Review of integrated molecular analyses of early-stage TGCT patients.
  • Analysis of molecular alterations in cisplatin-resistant TGCT cases.
  • Characterization of the role of epigenetics in TGCT development and prognosis.

Main Results:

  • Adult TGCTs exhibit frequent chromosomal anomalies and low somatic mutation rates, with common isochromosome 12p gain.
  • Mutations in genes like KIT and KRAS are confirmed, alongside novel mutations.
  • Cisplatin-resistant cases show high TP53-MDM2 axis alterations and actionable targets in PI3 kinase and MAPK pathways.

Conclusions:

  • Further molecular characterization of TGCT can help avoid overtreatment in early-stage disease.
  • Identifying molecular targets offers new treatment avenues for cisplatin-resistant TGCT.
  • Advanced understanding of TGCT biology supports personalized medicine and novel therapeutic development.